Funding biomedical research
Choosing research directions
ch. 3: Who owns the genome?
The Canavan disease patent case
ch. 4: Manufacturing children
Brave New World revisited
The Asilomar conference on recombinant DNA
ch. 5: Protecting the public
Placebo controls in clinical research
Setting limits on expert testimony
DNA forensics in criminal trials
ch. 8: Concealing evidence
The Academic-Industrial complex and conflict of Interest
The darker side of science
ch. 9: Science in the national interest
Limiting research in an age of bioterrorism
ch. 10: Science misunderstood
Mad cow disease, international trade and the loss of public trust
ch. 11: Dangers in the environment
ch. 12: Who lives and who dies?
Animals as organ factories
ch. 13: Concluding remarks
